WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008098196) TREPROSTINIL TREATMENT FOR INTERSTITIAL LUNG DISEASE AND ASTHMA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/098196    International Application No.:    PCT/US2008/053467
Publication Date: 14.08.2008 International Filing Date: 08.02.2008
IPC:
A61K 31/557 (2006.01), A61P 11/06 (2006.01), A61P 11/00 (2006.01)
Applicants: UNITED THERAPEUTICS CORPORATION [US/US]; 1110 Spring Street, Silver Spring, MD 20910 (US) (For All Designated States Except US).
WADE, Michael [US/US]; (US) (For US Only).
RICH, Stuart [US/US]; (US) (For US Only).
SULLIVAN, Eugene [US/US]; (US) (For US Only).
ROSCIGNO, Robert [US/US]; (US) (For US Only).
JEFFS, Roger [US/US]; (US) (For US Only)
Inventors: WADE, Michael; (US).
RICH, Stuart; (US).
SULLIVAN, Eugene; (US).
ROSCIGNO, Robert; (US).
JEFFS, Roger; (US)
Agent: MAEBIUS, Stephen, B.; Foley & Lardner Llp, Washington Harbour, 3000 K St., Nw, Suite 500, Washington, DC 20007 (US)
Priority Data:
60/900,320 09.02.2007 US
60/940,218 25.05.2007 US
Title (EN) TREPROSTINIL TREATMENT FOR INTERSTITIAL LUNG DISEASE AND ASTHMA
(FR) TRAITEMENT AU TRÉPROSTINIL D'UNE MALADIE PULMONAIRE INTERSTITIELLE ET DE L'ASTHME
Abstract: front page image
(EN)The present invention describes methods for using Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof, for the treatment and/or prevention of interstitial lung disease or asthma, or a condition, such as pulmonary fibrosis, associated with interstitial lung disease or a condition associated with asthma. The invention also relates to kits for treatment and/or prevention of such condition that include an effective amount of Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.
(FR)L'invention concerne des procédés d'utilisation du Tréprostinil ou d'un dérivé de ce composé, ou d'un sel pharmaceutiquement acceptable de celui-ci, pour traiter et/ou prévenir une maladie pulmonaire interstitielle ou l'asthme, ou un état pathologique tel que la fibrose pulmonaire associée à une maladie pulmonaire interstitielle ou un état pathologique associé à l'asthme. L'invention concerne aussi des trousses pour le traitement thérapeutique et/ou prophylactique d'un tel état, qui comprennent une quantité efficace de Tréprostinil ou d'un dérivé de ce composé, ou d'un sel pharmaceutiquement acceptable de celui-ci.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)